Loading...
Amantadine ER (Gocovri(®)) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease
Background: Clinical trials for antiparkinsonian drugs aimed at managing motor complications typically use patient diaries to divide levodopa-induced dyskinesias (LID) into “troublesome” and “non-troublesome” categories. Yet, given the choice, most patients would prefer to live without experiencing...
Na minha lista:
| Udgivet i: | Front Neurol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8032973/ https://ncbi.nlm.nih.gov/pubmed/33841311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.645706 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|